Publication | Closed Access

Daily ascending dosing in cynomolgus monkeys to mitigate cytokine release syndrome induced by ERY22, surrogate for T-cell redirecting bispecific antibody ERY974 for cancer immunotherapy

Cancer ImmunosurveillanceCynomolgus MonkeysBispecific Antibody Ery974ImmunologyTumor ImmunityImmunoeditingImmunologic MechanismImmune SurveillanceAutoimmunityCytokine Release SyndromeImmunomodulationImmunotherapyMedicineRadiation OncologyTumor Microenvironment